Please Wait

Applying Filters...

Vexol
USDMF
Table View

AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Vexol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF, 1 NDC API

FINISHED DOSAGE FORMULATIONS

9 FDF Dossiers, 1 FDA Orange Book, 8 Europe

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 7 Actylis, 1 BASF, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic

EXCIPIENTS BY APPLICATIONS

12 Solubilizers, 9 Parenteral, 3 Emulsifying Agents, 3 Topical, 2 Surfactant & Foaming Agents, 2 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Co-Processed Excipients, 1 Direct Compression